Insider Trading & Ownership - Piccina Cintia

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Piccina Cintia
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-06-18
Sale
2024-06-18
5:00 pm
Adaptimmune Therapeutics PLCADAPPiccina Cintia
Chief Commercial Officer
24,531$0.93$22,81438,293
(Direct)
View
2023-01-31
Sale
2023-01-31
9:02 pm
Adaptimmune Therapeutics PLCADAPPiccina Cintia
Chief Commercial Officer
11,890$1.8696$22,23019,535
(Direct)
View
2022-08-01
Sale
2022-08-01
9:00 pm
Adaptimmune Therapeutics PLCADAPPiccina Cintia
Chief Commercial Officer
21,040$1.7735$37,31434,824
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-18
Option Award
2024-03-18
5:00 pm
N/A
2034-03-18
Adaptimmune Therapeutics PLCADAPPiccina Cintia
Chief Commercial Officer
6,219,696$06,219,696
(Direct)
View
2023-07-03
Option Award
2023-07-05
5:00 pm
N/A
2033-07-03
Allovir Inc.ALVRPiccina Cintia
Chief Commercial Officer
420,000$0420,000
(Direct)
View
2023-01-17
Option Award
2023-01-17
9:02 pm
N/A
2033-01-17
Adaptimmune Therapeutics PLCADAPPiccina Cintia
Chief Commercial Officer
1,902,888$01,902,888
(Direct)
View
2022-01-31
Option Award
2022-01-31
9:05 pm
N/A
2032-01-31
Adaptimmune Therapeutics PLCADAPPiccina Cintia
Chief Commercial Officer
4,466,376$04,466,376
(Direct)
View